Literature DB >> 1569440

Prognostic factors for breast cancer: have they met their promise?

C K Osborne.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1569440     DOI： 10.1200/JCO.1992.10.5.679

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  p-Glycoprotein expression as a predictor of breast cancer recurrence.

Authors:  S Gregorcyk; Y Kang; D Brandt; P Kolm; G Singer; R R Perry
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

2.  Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer.

Authors:  J Y Pierga; A Leroyer; P Viehl; V Mosseri; S Chevillard; H Magdelénat
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index.

Authors:  Mu-Tai Liu; Wen-Tao Huang; Ai-Yih Wang; Chia-Chun Huang; Chao-Yuan Huang; Tung-Hao Chang; Chu-Pin Pi; Hao-Han Yang
Journal:  Support Care Cancer       Date:  2009-11-11       Impact factor: 3.603

4.  Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parameters.

Authors:  M Bolla; M Chedin; M Colonna; J Marron-Charrière; B Rostaing-Puissant; D Pasquier; M H Panh; P Winckel; E M Chambaz
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Do we really need prognostic factors for breast cancer?

Authors:  G M Clark
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  New therapeutic possibilities in primary invasive breast cancer.

Authors:  B Cady; M D Stone; J Wayne
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

7.  Prospective evaluation of prognostic factors in operable breast cancer.

Authors:  R A Hawkins; A L Tesdale; M E Killen; W J Jack; U Chetty; J M Dixon; M J Hulme; R J Prescott; M A McIntyre; W R Miller
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

8.  Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.

Authors:  A Scorilas; T Trangas; J Yotis; C Pateras; M Talieri
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

9.  Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.

Authors:  Y Ogawa; Y S Chung; B Nakata; S Takatsuka; K Maeda; T Sawada; Y Kato; K Yoshikawa; M Sakurai; M Sowa
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

10.  The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

Authors:  P Manders; L V A M Beex; V C G Tjan-Heijnen; J Geurts-Moespot; T H Van Tienoven; J A Foekens; C G J Sweep
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.